Chemomab Therapeutics Ltd.
Overview
Chemomab Therapeutics Ltd. is a clinical-stage biotechnology company focused on developing innovative therapeutics for the treatment of fibrotic and inflammatory diseases. The company is committed to advancing its pipeline of monoclonal antibody-based treatments to address unmet medical needs in these therapeutic areas.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Chemomab Therapeutics Ltd. in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.
Is this Chemomab Therapeutics Ltd.?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.